We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+0.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$360B
AUM Growth
-$5.05B
Cap. Flow
-$2.61B
Cap. Flow %
-0.72%
Top 10 Hldgs %
13.81%
Holding
6,930
New
170
Increased
3,227
Reduced
2,806
Closed
155

Sector Composition

Rank Sector Weight
1 Technology 11.4%
2 Financials 10.07%
3 Consumer Discretionary 8.39%
4 Healthcare 7.69%
5 Communication Services 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTBR icon
6226
Lightbridge
LTBR
$266M
$4K ﹤0.01%
315
-7
-2% -$133
MIND icon
6227
MIND Technology
MIND
$44.8M
$4K ﹤0.01%
113
+80
+242% +$2.82K
NTIC icon
6228
Northern Technologies International Corp
NTIC
$76.5M
$4K ﹤0.01%
382
-56
-13% -$652
PERI icon
6229
Perion Network
PERI
$369M
$4K ﹤0.01%
1,529
-4,835
-76% -$14K
SKOR icon
6230
FlexShares Credit-Scored US Corporate Bond Index Fund
SKOR
$729M
$4K ﹤0.01%
84
TTNP
6231
DELISTED
Titan Pharmaceuticals
TTNP
$4K ﹤0.01%
1
-1
-50% -$4.18K
VRNA
6232
DELISTED
Verona Pharma
VRNA
$4K ﹤0.01%
201
+186
+1,240% +$2.69K
XBIO icon
6233
Xenetic Biosciences
XBIO
$5.93M
$4K ﹤0.01%
17
XWEL icon
6234
XWELL
XWEL
$8.95M
$4K ﹤0.01%
5
+2
+67% +$2.44K
YXI icon
6235
ProShares Short FTSE China 50 of PROSHARES TRUST
YXI
$4.36M
$4K ﹤0.01%
100
SOFO
6236
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
$4K ﹤0.01%
2,001
AUTO
6237
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$4K ﹤0.01%
1,142
-24,490
-96% -$169K
GSB
6238
DELISTED
GlobalSCAPE, Inc.
GSB
$4K ﹤0.01%
962
-1,388
-59% -$4.92K
MELR
6239
DELISTED
Melrose Bancorp, Inc.
MELR
$4K ﹤0.01%
201
ONCS
6240
DELISTED
OncoSec Medical Incorporated
ONCS
$4K ﹤0.01%
10
+3
+43% +$1.23K
LBCC
6241
DELISTED
Long Blockchain Corp. Common Stock
LBCC
$4K ﹤0.01%
1,515
+1,327
+706% +$4.66K
AHG
6242
Akso Health Group
AHG
$1.27B
$3K ﹤0.01%
100
+89
+809% +$2.95K
ASEA icon
6243
Global X FTSE Southeast Asia ETF
ASEA
$98.9M
$3K ﹤0.01%
158
-615
-80% -$10.9K
CFBK icon
6244
CF Bankshares
CFBK
$237M
$3K ﹤0.01%
210
+55
+35% +$756
COE
6245
51Talk Online Education Group
COE
$104M
$3K ﹤0.01%
90
+77
+592% +$3.53K
CRMD icon
6246
CorMedix
CRMD
$584M
$3K ﹤0.01%
2,801
+161
+6% +$321
CSPI icon
6247
CSP Inc
CSPI
$81.1M
$3K ﹤0.01%
600
-1,200
-67% -$8.51K
CURE icon
6248
Direxion Daily Healthcare Bull 3X ETF
CURE
$177M
$3K ﹤0.01%
61
-3,471
-98% -$174K
DSS icon
6249
DSS Inc
DSS
$5.09M
$3K ﹤0.01%
4
+1
+33% +$828
FPAY
6250
DELISTED
FlexShopper
FPAY
$3K ﹤0.01%
1,015
+990
+3,960% +$3.39K

Similar funds

Morgan Stanley's Q1 2018 Portfolio in Review

As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 170 new positions and exited 155, leaving the 6,930-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
  • Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
  • Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
  • Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
  • Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
  • Morgan Stanley opened 170 new positions and closed 155 in Q1 2018.
  • Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.

Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.